{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:23:03Z","timestamp":1773984183545,"version":"3.50.1"},"reference-count":58,"publisher":"Wiley","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ane.12840","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T13:50:37Z","timestamp":1508939437000},"page":"37-44","source":"Crossref","is-referenced-by-count":22,"special_numbering":"supplement S201","title":["The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy"],"prefix":"10.1155","volume":"136","author":[{"given":"A. Q.","family":"Reuwer","sequence":"first","affiliation":[{"name":"Laboratory of Medical Microbiology and Immunology; St. Elisabeth Hospital Tilburg; Tilburg The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heron","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology and Immunology; St. Elisabeth Hospital Tilburg; Tilburg The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"van der Dussen","sequence":"additional","affiliation":[{"name":"Department of Neurology; University Medical Centre Utrecht; Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schneider-Hohendorf","sequence":"additional","affiliation":[{"name":"Department of Neurology; University of Munster; Munster Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Murk","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology and Immunology; St. Elisabeth Hospital Tilburg; Tilburg The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"10.1111\/ane.12840-BIB0001|ane12840-cit-0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","article-title":"Classifying PML risk with disease modifying therapies","volume":"12","author":"Berger","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1111\/ane.12840-BIB0002|ane12840-cit-0002","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00415-016-8217-x","article-title":"Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases","volume":"263","author":"Maas","year":"2016","journal-title":"J Neurol"},{"key":"10.1111\/ane.12840-BIB0003|ane12840-cit-0003","unstructured":"Biogen Medical information natalizumab https:\/\/medinfo.biogen.com\/secure\/pmlresource"},{"key":"10.1111\/ane.12840-BIB0004|ane12840-cit-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0168376","article-title":"Natalizumab-related progressive multifocal leukoencephalopathy in multiple sclerosis: findings from an Italian independent registry","volume":"11","author":"Prosperini","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1111\/ane.12840-BIB0005|ane12840-cit-0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apm.12128","article-title":"The human JC polyomavirus (JCPyV): virological background and clinical implications","volume":"121","author":"Hirsch","year":"2013","journal-title":"APMIS"},{"key":"10.1111\/ane.12840-BIB0006|ane12840-cit-0006","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12948","article-title":"Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency","volume":"188","author":"Misbah","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/ane.12840-BIB0007|ane12840-cit-0007","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jiq097","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy - Revisited","volume":"203","author":"White","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1111\/ane.12840-BIB0008|ane12840-cit-0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","article-title":"Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies","volume":"61","author":"Major","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1111\/ane.12840-BIB0009|ane12840-cit-0009","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.02565-14","article-title":"JC Virus Quasispecies Analysis Reveals a Complex Viral Population Underlying Progressive Multifocal Leukoencephalopathy and Supports Viral Dissemination via the Hematogenous Route","volume":"89","author":"Van Loy","year":"2015","journal-title":"J Virol"},{"key":"10.1111\/ane.12840-BIB0010|ane12840-cit-0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570162X1401151102125319","article-title":"Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy","volume":"14","author":"Wollebo","year":"2016","journal-title":"Curr HIV Res"},{"key":"10.1111\/ane.12840-BIB0011|ane12840-cit-0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression","volume":"81","author":"Gheuens","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12840-BIB0012|ane12840-cit-0012","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10096-013-1941-6","article-title":"Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV\/AIDS patients in the current era","volume":"33","author":"Casado","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/ane.12840-BIB0013|ane12840-cit-0013","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/598335","article-title":"Incidence and outcome of progressive multifocal leukoencephalopathy over 20\u00a0years of the Swiss HIV Cohort Study","volume":"48","author":"Khanna","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ane.12840-BIB0014|ane12840-cit-0014","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.168.1.499","article-title":"Response Specific for a Commonly Recognized JC Virus","volume":"168","author":"Koralnik","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/ane.12840-BIB0015|ane12840-cit-0015","first-page":"6","article-title":"Immune system involvement in the pathogenesis of JC Virus induced PML What is learned from studies of patients with underlying diseases and therapies as risk factors","volume":"28","author":"Monaco","year":"2015","journal-title":"Front Immunol"},{"key":"10.1111\/ane.12840-BIB0016|ane12840-cit-0016","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00415-017-8509-9","article-title":"Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases","volume":"264","author":"Gieselbach","year":"2017","journal-title":"J Neurol"},{"key":"10.1111\/ane.12840-BIB0017|ane12840-cit-0017","first-page":"241","article-title":"B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link","author":"Durali","year":"2015","journal-title":"Front Immunol"},{"key":"10.1111\/ane.12840-BIB0018|ane12840-cit-0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1111\/ane.12840-BIB0019|ane12840-cit-0019","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri.2016.144","article-title":"T cell responses in the central nervous system","volume":"17","author":"Korn","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/ane.12840-BIB0020|ane12840-cit-0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.aag2638","article-title":"Multifaceted interactions between adaptive immunity and the central nervous system","volume":"353","author":"Kipnis","year":"2016","journal-title":"Science"},{"key":"10.1111\/ane.12840-BIB0021|ane12840-cit-0021","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/ane.12840-BIB0022|ane12840-cit-0022","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/ane.12840-BIB0023|ane12840-cit-0023","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20151916","article-title":"Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection","volume":"213","author":"Steinbach","year":"2016","journal-title":"J Exp Med"},{"key":"10.1111\/ane.12840-BIB0024|ane12840-cit-0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/B978-0-443-06839-3.00006-0","volume-title":"Mandell, Douglas, and Bennet's Principles and Practice of Infectious Diseases","author":"Birdsall","year":"2010","edition":"7"},{"key":"10.1111\/ane.12840-BIB0025|ane12840-cit-0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/ane.12840-BIB0026|ane12840-cit-0026","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.virol.2015.08.022","article-title":"BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients","volume":"485","author":"Rossi","year":"2015","journal-title":"Virology"},{"key":"10.1111\/ane.12840-BIB0027|ane12840-cit-0027","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.80.7.3495-3505.2006","article-title":"Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy","volume":"80","author":"Chen","year":"2006","journal-title":"J Virol"},{"key":"10.1111\/ane.12840-BIB0028|ane12840-cit-0028","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ene.12988","article-title":"High cumulative JC virus seroconversion rate during long-term use of natalizumab","volume":"23","author":"Vennegoor","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12840-BIB0029|ane12840-cit-0029","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1212\/NXI.0000000000000195","article-title":"Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values","volume":"3","author":"Schwab","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1111\/ane.12840-BIB0030|ane12840-cit-0030","doi-asserted-by":"crossref","first-page":"306ra151","DOI":"10.1126\/scitranslmed.aab1720","article-title":"JC polyomavirus mutants escape antibody-mediated neutralization","volume":"7","author":"Ray","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1111\/ane.12840-BIB0031|ane12840-cit-0031","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.4049\/jimmunol.153.5.2064","article-title":"Immunization of BALB\/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity","volume":"153","author":"Bright","year":"1994","journal-title":"J Immunol"},{"key":"10.1111\/ane.12840-BIB0032|ane12840-cit-0032","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.0b013e3182a43e6d","article-title":"In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection","volume":"10","author":"Martin-Blondel","year":"2013","journal-title":"Neurology"},{"key":"10.1111\/ane.12840-BIB0033|ane12840-cit-0033","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/CVI.00136-16","article-title":"Inhibitory Antibodies Targeting Emerging Viruses: advancements and Mechanisms","volume":"23","author":"Jin","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/ane.12840-BIB0034|ane12840-cit-0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC Virus Antibodies: Implications for PML Risk Stratification","volume":"68","author":"Gorelik","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12840-BIB0035|ane12840-cit-0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12840-BIB0036|ane12840-cit-0036","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1086\/514617","article-title":"Progressive multifocal leukoencephalopathy in a patient with hypogammaglobulinemia","volume":"27","author":"Bezrodnik","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ane.12840-BIB0037|ane12840-cit-0037","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/00365540310016673","article-title":"Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia","volume":"35","author":"Teramoto","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/ane.12840-BIB0038|ane12840-cit-0038","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jns.2009.04.035","article-title":"Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia","volume":"284","author":"Tasca","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1111\/ane.12840-BIB0039|ane12840-cit-0039","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/clinids\/9.2.334","article-title":"Chronic enteroviral meningoencephalitis in agammaglobulinemic patients","volume":"9","author":"McKinney","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1111\/ane.12840-BIB0040|ane12840-cit-0040","unstructured":"Diagnostics F. Stratify JCV RevB http:\/\/www.focusdx.com\/pdfs\/pi\/OUS\/EL1950-5.CAN.pdf"},{"key":"10.1111\/ane.12840-BIB0041|ane12840-cit-0041","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.0000000000002330","article-title":"Natalizumab-related PML 2\u00a0weeks after negative anti-JCV antibody assay","volume":"86","author":"Gagne Brosseau","year":"2016","journal-title":"Neurology"},{"key":"10.1111\/ane.12840-BIB0042|ane12840-cit-0042","first-page":"205521731663000","article-title":"Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy","volume":"2","author":"Salmen","year":"2016","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1111\/ane.12840-BIB0043|ane12840-cit-0043","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0000000000003739","article-title":"Natalizumab-associated PML: challenges with incidence, resulting risk, and risk stratification","volume":"88","author":"Schwab","year":"2017","journal-title":"Neurology"},{"key":"10.1111\/ane.12840-BIB0044|ane12840-cit-0044","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cir507","article-title":"John cunningham virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals","volume":"53","author":"Viscidi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ane.12840-BIB0045|ane12840-cit-0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0174005","article-title":"Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study","volume":"12","author":"Hegen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1111\/ane.12840-BIB0046|ane12840-cit-0046","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/1352458515599681","article-title":"Anti-JC virus antibody titres increase over time with natalizumab treatment","volume":"21","author":"Raffel","year":"2015","journal-title":"Mult Scler"},{"key":"10.1111\/ane.12840-BIB0047|ane12840-cit-0047","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/jnnp-2012-304332","article-title":"Changes to anti-JCV antibody levels in a Swedish national MS cohort","volume":"84","author":"Warnke","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12840-BIB0048|ane12840-cit-0048","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","article-title":"A second-generation ELISA (STRATIFY JCV\u2122 DxSelect\u2122) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification","volume":"57","author":"Lee","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1111\/ane.12840-BIB0049|ane12840-cit-0049","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.msard.2016.06.014","article-title":"Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: case report","volume":"9","author":"Miranda Acu\u00f1a","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1111\/ane.12840-BIB0050|ane12840-cit-0050","doi-asserted-by":"crossref","first-page":"e29.","DOI":"10.1212\/NXI.0000000000000029","article-title":"IV immunoglobulin confounds JC virus antibody serostatus determination","volume":"1","author":"Kister","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1111\/ane.12840-BIB0051|ane12840-cit-0051","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2017.03.015","article-title":"Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia","volume":"90","author":"Wunderink","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1111\/ane.12840-BIB0052|ane12840-cit-0052","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ajt.13880","article-title":"Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation","volume":"17","author":"Wunderink","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/ane.12840-BIB0053|ane12840-cit-0053","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00430-011-0200-7","article-title":"Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer","volume":"201","author":"Pastrana","year":"2012","journal-title":"Med Microbiol Immunol"},{"key":"10.1111\/ane.12840-BIB0054|ane12840-cit-0054","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.24153","article-title":"Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Warnke","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12840-BIB0055|ane12840-cit-0055","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2016-315298","article-title":"Application of the CSF JCV antibody index to early natalizumab- associated progressive multifocal leukoencephalopathy","author":"Warnke","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12840-BIB0056|ane12840-cit-0056","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1111\/ane.12840-BIB0057|ane12840-cit-0057","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2016.21","article-title":"Disease-modifying therapies and infectious risks in multiple sclerosis","volume":"12","author":"Winkelmann","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1111\/ane.12840-BIB0058|ane12840-cit-0058","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1212\/NXI.0000000000000072","article-title":"Fatal acute liver failure with hepatitis B virus infection during natalizumab treatment in multiple sclerosis","volume":"2","author":"Hillen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12840","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12840\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T15:00:54Z","timestamp":1693148454000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":58,"URL":"https:\/\/doi.org\/10.1111\/ane.12840","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}